|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| A61K 38/17 | |||
| A61P 7/06 |
| (11) | Number of the document | 2303917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09770553.7 |
| Date of filing the European patent application | 2009-06-26 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/003808 |
| Date | 2009-06-26 |
| (87) | Number | WO 2009/158015 |
| Date | 2009-12-30 |
| (30) | Number | Date | Country code |
| 133368 P | 2008-06-26 | US |
| (72) |
SHERMAN, Matthew, L., US
SEEHRA, Jasbir, US
BORGSTEIN, Niels, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS |
| ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS |